首页> 美国卫生研究院文献>The Journal of Physiology >In vivo characterization of renal iron transport in the anaesthetized rat
【2h】

In vivo characterization of renal iron transport in the anaesthetized rat

机译:麻醉大鼠中肾铁转运的体内特征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">In vivo microinjections of 55FeCl3 were made to assess renal iron (Fe2+/3+) transport in the anaesthetized rat.Following microinjection into proximal convoluted tubules (PCTs), 18·5 ± 2·9 % (mean ± s.e.m., n = 11) of the 55Fe was recovered in the urine. This recovery was not dependent on the injection site indicating that iron is not reabsorbed across the surface convolutions of the proximal tubule.Following microinjection into distal convoluted tubules (DCTs) 46·1 ± 6·1 % (n = 8) of the injected 55Fe was recovered. Taken together the recovery data from the PCT and DCT microinjection studies indicate that the transport of iron occurs in the loop of Henle (LH) and collecting duct system.In vivo luminal microperfusion was used to examine iron transport by the LH in more detail. In tubules perfused with 7 μmol l−155FeCl3, 52·7 ± 8·3 % (n = 8) of the perfused 55Fe was recovered in the collected fluid, indicating significant iron reabsorption in the LH. Addition of copper (Cu2+ as 7 μmol l−1 CuSO4), manganese (Mn2+ as 7 μmol l−1 MnSO4) or zinc (Zn2+ as 7 μmol l−1 ZnSO4) to the perfusate did not affect reabsorption of water, Na+ or K+, but increased recovery of 55Fe to 83·5 ± 6·8 % (n = 8, P < 0·04), 75·8 ± 5·9 (n = 6, not significant, n.s.) and 67·9 ± 3·8; (n = 9, n.s.), respectively.Thus, iron transport in the LH can be reduced by the addition of copper or manganese to the luminal perfusate suggesting that these ions may compete with iron for a common transport pathway. However, this pathway may not be shared by zinc.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 进行体内 55 FeCl3显微注射以评估麻醉大鼠中肾铁(Fe 2 + / 3 + )的转运。 显微注射后在尿液中回收了 55 Fe的近端曲折小管(PCTs)中的18·5±2·9%(平均值±sem,n = 11)。这种恢复并不取决于注射部位,这表明铁不会在近端小管的表面回旋处重新吸收。 显微注射到远端回旋小管(DCT)中46·1±6·1%(n = 8)回收了注入的 55 Fe。结合PCT和DCT显微注射研究的回收数据表明,铁的运输发生在Henle(LH)回路和收集管道系统中。 体内腔内微灌流通过流式细胞术检测铁的运输LH更详细。在用7μmoll −1 55 FeCl3灌注的小管中,灌注的 55 的52·7±8·3%(n = 8)铁在收集的流体中被回收,表明LH中铁的重吸收明显。添加铜(Cu 2 + 为7μmoll -1 CuSO4),锰(Mn 2 + 作为7μmoll − 1 MnSO4)或锌(Zn 2 + 为7μmoll −1 ZnSO4)对灌注液的影响不影响水的再吸收,Na + 或K + ,但 55 Fe的回收率提高到83·5±6·8%(n = 8,P <0·04),75 ·8±5·9(n = 6,无效,ns)和67·9±3·8; (n = 9,ns)。 因此,可以通过向腔内灌注液中添加铜或锰来减少LH中的铁迁移,这表明这些离子可能与铁竞争共同的迁移途径。但是,锌可能不会共享该途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号